§ Funding Round
Series B funding round for Arkuda Therapeutics raising $64M in February 2022
Series B funding round for Arkuda Therapeutics raising $64M in February 2022
| Investor | Firm Type | Partner |
|---|---|---|
| Organization | — | |
| Organization | — | |
EQT Life Sciences | — | — |
| Organization | — | |
| Organization | — | |
SR One | — | — |
raymond kelleherLEAD | Angel | raymond kelleher |
Eli Lilly and Company | — | — |
Mission BioCapital | — | — |
Surveyor Capital | — | — |
This company has completed 2 funding rounds. Current round is highlighted.
Total Raised
$108M
Top Valuation
-
Arkuda Therapeutics raised $64M in a Series B round.
The round was announced on 02/01/22.
The round was led by Pivotal bioVenture Partners, raymond kelleher.
